Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats

Bone

Volumn 35, Issue 4, 2004, Pages 870-880

  Asawa, Y ^a   Amizuka, N ^a,b   Hara, K ^c   Kobayashi, M ^c   Aita, M ^a   Li, M ^a   Kenmotsu, S ^a   Oda, K ^a,b   Akiyama, Y ^c   Ozawa, H ^d  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c EISAI CO LTD   (Japan)

^d MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

Autoradiography; Histochemistry; Osteoclast; Ovariectomy; Vitamin K2 (menatetorenon)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; MENATETRENONE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BONE MATRIX; CARTILAGE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG TARGETING; FEMALE; FEMUR; HISTOCHEMISTRY; ISOTOPE LABELING; METAPHYSIS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; RAT; TRABECULAR BONE;

ANIMALS; ANIMALS, NEWBORN; AUTORADIOGRAPHY; BONE DENSITY; FEMALE; FEMUR; MICE; MICROSCOPY, ELECTRON; OSTEOCALCIN; OSTEOCLASTS; OVARIECTOMY; RATS; RATS, INBRED F344; TIME FACTORS; VITAMIN K 2;

EID: 5344238901     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.06.007     Document Type: Article

References (42)

1. Hauschka P.V., Lian J.B., Gallop P.M. Direct identification of the calcium-binding amino acids, γ-calboxyglutamate, in mineralized tissue. Proc. Natl. Acad. Sci. U. S. A. 72:1975;3925-3929
2. Price P.A., Otsuka A.S., Poser J.W., Kristaponis J., Raman N. Characterization of a γ-carboxyglutamic acid containing protein from bone. Proc. Natl. Acad. Sci. U. S. A. 73:1976;1447-1451
3. Cairns J.R., Price P.A. Direct demonstration that the vitamin K-dependent bone Gla protein is incompletely γ-carboxylated in humans. J. Bone Miner. Res. 9(12):1994;1989-1997
4. Price P.A., Nishimoto S.K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc. Natl. Acad. Sci. U. S. A. 77(4):1980;2234-2238
5. Price P.A., Williamson M.K. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J. Biol. Chem. 260(28):1985;14971-14975
6. Hauschka P.V., Carr S.A. Calcium-dependent alpha-helical structure in osteocalcin. Biochemistry. 21(10):1982;2538-2547
7. Hart J.P., Shearer M.J., Klenerman L., Catterall A., Reeve J., Sambrook P.N., et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis. J. Clin. Endocrinol. Metab. 60(6):1985;1268-1269
8. Szulc P., Chapuy M.C., Meunier P.J., Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J. Clin. Invest. 91(4):1993;1769-1774
9. Booth S.L., Tucker K.L., Chen H., Hannan M.T., Gagnon D.R., Cupples L.A., et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am. J. Clin. Nutr. 71(5):2000;1201-1208
10. Feskanich D., Weber P., Willett W.C., Rockett H., Booth S.L., Colditz G.A. Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 69(1):1999;74-79
11. Szulc P., Chapuy M.C., Meunier P.J., Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone. 18(5):1996;487-488
12. Akiyama Y., Hara K., Ohkawa I., Tajima T. Effects of menatetrenone on bone loss induced by ovariectomy in rats. Jpn. J. Pharmacol. 62:1993;145-153
13. Akiyama Y., Hara K., Kobayashi M., Tomiuga T., Nakamura T. Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study. Jpn. J. Pharmacol. 80(1):1999;67-74
14. Onodera K., Takahashi A., Sakurada S., Okano Y. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats. Life Sci. 70(13):2002;1533-1542
15. Hara K., Akiyama Y., Ohkawa I., Tajima T. Effects of menatetenone on prednisolone-induced bone loss in rats. Bone. 14:1993;813-818
16. Hara K., Kobayashi M., Akiyama Y. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone. 31(5):2002;575-581
17. Ushiroyama T., Ikeda A., Ueki M. Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas. 41:2002;211-221
18. Akiyama Y., Hara K., Tajima T., Murota S., Morita I. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur. J. Pharmacol. 263:1994;181-185
19. Hara K., Akiyama Y., Tajima T., Shiraki M. Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitro. J. Bone Miner. Res. 8:1993;535-542
20. Koshihara Y., Hoshi K., Shiraki M. Vitamin K2 (menatetrenone) inhibits prostaglandin synthesis in cultured human osteoblast-like periosteal cells by inhibiting prostaglandin H synthase activity. Biochem. Pharmacol. 46(8):1993;1355-1362
21. Kameda T., Miyazawa K., Mori Y., Yuasa T., Shiokawa M., Nakamaru Y., et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem. Biophys. Res. Commun. 220(3):1996;515-519
22. Binkley N., Krueger D., Engelke J., Crenshaw T., Suttie J. Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats. Bone. 30:2002;897-900
23. Amizuka N., Ozawa H. Intracellular localization and translocation of 1α,25(OH)2D3 receptor in osteoblasts. Arch. Histol. Cytol. 55:1992;77-88
24. Amizuka N., Yamada M., Watanabe J., Hoshi K., Fukushi M., Oda K., et al. Morphological examination of bone synthesis via direct administration of basic fibroblast growth factor into rat bone marrow. Microsc. Res. Tech. 41:1998;313-322
25. Oda K., Amaya Y., Fukushi-Irie M., Kinameri Y., Ohsuye K., Kubota I., et al. A general method for rapid purification of soluble versions of glycosylphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase. J. Biochem. 126:1999;694-699
26. Burstone M.S. Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J. Natl. Cancer Inst. 21(3):1958;523-539
27. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., Karaplis A.C. Parathyroid hormone related peptide (PTHrP)-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell Biol. 126:1994;1611-1623
28. Asahito T., Ohshima H., Hanada K., Wakisaka S., Maeda T. Postnatal expression of calretinin-immunoreactivity in periodontal Ruffini endings in the rat incisor: a comparison with protein gene product 9.5 (PGP 9.5)-immunoreactivity. Arch. Histol. Cytol. 62(1):1999;57-69
29. Harada F., Hoshino N., Hanada K., Kawano Y., Atsumi Y., Wakisaka S., et al. The involvement of brain-derived neurotrophic factor (BDNF) in the regeneration of periodontal Ruffini endings following transection of the inferior alveolar nerve. Arch. Histol. Cytol. 66(2):2003;183-194
30. Shiraishi A., Higashi S., Masaki T., Saito M., Ito M., Ikeda S., et al. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif. Tissue Int. 71(1):2002;69-79
31. Mawatari T., Miura H., Higaki H., Moro-Oka T., Kurata K., Murakami T., et al. Effect of vitamin K2 on three-dimensional trabecular microarchitecture in ovariectomized rats. J. Bone Miner. Res. 15(9):2000;1810-1817
32. Shiraki M., Shiraki Y., Aoki C., Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumber bone mineral density in osteoporosis. J. Bone Miner. Res. 15(3):2000;515-521
33. Xin F., Takemitsu M., Atsuta Y. Effect of vitamin K2 on lumber vertebral bone: histomorphometric analysis in experimental osteoporotic rats. J. Orthop. Sci. 6:2001;535-539
34. Suttie J.W. Vitamin K-dependent carboxylase. Annu. Rev. Biochem. 54:1985;459-477
35. Suttie J.W. Studies of the vitamin K-dependent carboxylase and vitamin K episode reductase in rat liver. Haemostasis. 16:1986;193-215
36. Vermeer C. The role of vitamin K in the posttranslational modification of proteins. Zwaal R.F.A., Hemker H.C. Blood coagulation. 1986;87 Elsevier, New York
37. Takeuchi Y., Suzawa M., Fukumoto S., Fujita T. Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression inn murine bone marrow cell cultures. Bone. 27(6):2000;767-776
38. Hara K., Akiyama Y., Nakamura T., Murota S., Morita I. The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain. Bone. 16(2):1995;179-184
39. Yamaguchi M., Sugimoto E., Hachiya S. Stimulatory effect of menatetrenone-7 (vitamin K2) on osteoblastic bone formation in vitro. Mol. Cell. Biochem. 223:2001;131-137
40. Koshihara Y., Hoshi K., Okawara R., Ishibashi H., Yamamoto S. Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. J. Endocrinol. 176(3):2003;339-348
41. Hoshi K., Nomura K., Sano Y., Koshihara Y. Nuclear vitamin K2 binding protein in human osteoblasts: homologue to glyceraldehyde-3-phosphate dehydrogenase. Biochem. Pharmacol. 58(10):1999;1631-1638
42. Tabb M.M., Sun A., Zhou C., Grun F., Errandi J., Romero K., et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J. Biol. Chem. 278(45):2003;43919-43927